Discovery & Innovation
Last year, Scientist announced our winners for the Rare Disease Challenge, as part of our efforts to raise awareness for rare diseases. We know how...
We previously discussed how there are software methods to screen for potential drug leads and researchers have been able to increase their drug...
If you hobnob around scientists, you might be increasingly hearing the mysterious acronym “CRISPR” being mentioned in conversation. CRISPR...
Previously, we discussed in part 1 of this series the growing significance of computational methods in drug discovery. Traditional drug discovery...
Most people have probably heard of Alexander Fleming’s chance encounter with a penicillin-producing fungus. What is not quite well-known is that...
Traditional drug discovery is expensive, inefficient, and has huge barriers to entry. Big pharmaceutical companies continue to struggle to cope...
A quick scan of recent advances in the scientific community will show that genomic data and new techniques in next-gen sequencing have been gaining...
This is the third and final post of a series (part 1 and part 2) on directed evolution. What do protein engineers actually produce using directed...
Three outstanding examples for fragment-based drug discovery A good example for the reliability of the fragment-based screening method is the...
Directed evolution is emerging as a powerful new tool to design proteins with new and interesting properties that may not have evolved naturally...